Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
Two more people sentenced for carjacking and kidnapping an FBI employee in South Dakota
RAPID CITY, S.D. (AP) — The last two members of a trio who carjacked and kidnapped an FBI employee i2024-05-01Ecuador violence: Ecuadorians approve referendum measures to toughen fight against gangs
QUITO, Ecuador (AP) — Ecuador’s fledgling president got a resounding victory Sunday in a referendum2024-05-01Chinese readers find new passion for scientific literature
BEIJING, April 21 (Xinhua) -- On Douyin, China's most popular video-sharing platform, a program dedi2024-05-01- NEW YORK (AP) — A longtime tabloid publisher was expected Tuesday to tell jurors about his efforts t2024-05-01
Top Chinese diplomat meets with executive secretary of ESCAP
Chinese Foreign Minister Wang Yi met with Armida Salsiah Alisjahbana, Executive Secretary of United2024-05-01David Beckham gushes over his wife Victoria's age
David Beckham has continued to gush over his wife Victoria on social media in the wake of her 50th b2024-05-01
atest comment